EVROF — Evrofarma SA Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapSuper Stock

Annual balance sheet for Evrofarma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.11	0.249	1.44	0.657	3.32
Net Total Accounts Receivable
Net Total Receivables	12.2	13.7	11.7	9.17	7.37
Total Inventory
Total Other Current Assets
Total Current Assets	18.8	17	18.7	16.3	17.8
Net Property, Plant And Equipment	26.7	28.7	29.3	30	29.7
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	46.4	46.5	48.8	47.4	48.2
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.7	10.2	12.7	13	18.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	33.4	33.9	34.8	31.1	30.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13	12.6	14	16.2	17.8
Total Liabilities & Shareholders' Equity	46.4	46.5	48.8	47.4	48.2
Total Common Shares Outstanding